Histological, epidemiological and anatomical analysis of 193 bone tumours of the scapula

Standard

Histological, epidemiological and anatomical analysis of 193 bone tumours of the scapula. / Priemel, Matthias H; Erler, Johannes M E; Zustin, Jozef; Luebke, Andreas M; Stiel, Norbert; Spiro, Alexander S.

In: J BONE ONCOL, Vol. 18, 10.2019, p. 100258.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{5b3c1d21c8c648c6af2ac4dfa702489f,
title = "Histological, epidemiological and anatomical analysis of 193 bone tumours of the scapula",
abstract = "Backround: This study aimed to determine the frequency and distribution of bone tumours of the scapula as well as the histological and anatomical characteristics of these rare lesions in a large case series.Methods: The records of all lesions of the scapula collected from 1975 to 2018 in our bone tumour registry and institute of pathology were evaluated. During these 43 years, 223 cases were identified. Analysis included assessment of age, gender, side, imaging findings, tumour location, and histological evaluation with the assignment of each lesion to one of the bone tumours according to the World Health Organization (WHO) classification of bone tumours.Results: Bone tumours of the scapula were found in 193 cases. Mean patient age was 38.4 years (2.6-82.4). Most of the lesions were of cartilage origin (47%). 59 bone tumours were benign (30.6%), 29 were intermediate (15.0%), and 105 were malignant (54.4%). The most commonly found bone tumour was Osteochondroma (23.3%), followed by Chondrosarcoma (17.6%), Bone metastases (16.6%), Ewing sarcoma (8.8%), and Osteosarcoma (7.8%). The percentage of malignant bone tumours increased with increasing age. In patients >50 years of age, 91% had a malignant lesion of the scapula.Conclusions: Evaluation of 193 bone tumours of the scapula revealed a high incidence of malignancy in this series, while increased patient age was identified as a potential risk factor for the development of a malignant lesion of the scapula. These findings highlight the importance of early diagnosis and treatment of suspicious lesions of the scapula to improve patient outcome.",
author = "Priemel, {Matthias H} and Erler, {Johannes M E} and Jozef Zustin and Luebke, {Andreas M} and Norbert Stiel and Spiro, {Alexander S}",
year = "2019",
month = oct,
doi = "10.1016/j.jbo.2019.100258",
language = "English",
volume = "18",
pages = "100258",
journal = "J BONE ONCOL",
issn = "2212-1374",
publisher = "Elsevier GmbH",

}

RIS

TY - JOUR

T1 - Histological, epidemiological and anatomical analysis of 193 bone tumours of the scapula

AU - Priemel, Matthias H

AU - Erler, Johannes M E

AU - Zustin, Jozef

AU - Luebke, Andreas M

AU - Stiel, Norbert

AU - Spiro, Alexander S

PY - 2019/10

Y1 - 2019/10

N2 - Backround: This study aimed to determine the frequency and distribution of bone tumours of the scapula as well as the histological and anatomical characteristics of these rare lesions in a large case series.Methods: The records of all lesions of the scapula collected from 1975 to 2018 in our bone tumour registry and institute of pathology were evaluated. During these 43 years, 223 cases were identified. Analysis included assessment of age, gender, side, imaging findings, tumour location, and histological evaluation with the assignment of each lesion to one of the bone tumours according to the World Health Organization (WHO) classification of bone tumours.Results: Bone tumours of the scapula were found in 193 cases. Mean patient age was 38.4 years (2.6-82.4). Most of the lesions were of cartilage origin (47%). 59 bone tumours were benign (30.6%), 29 were intermediate (15.0%), and 105 were malignant (54.4%). The most commonly found bone tumour was Osteochondroma (23.3%), followed by Chondrosarcoma (17.6%), Bone metastases (16.6%), Ewing sarcoma (8.8%), and Osteosarcoma (7.8%). The percentage of malignant bone tumours increased with increasing age. In patients >50 years of age, 91% had a malignant lesion of the scapula.Conclusions: Evaluation of 193 bone tumours of the scapula revealed a high incidence of malignancy in this series, while increased patient age was identified as a potential risk factor for the development of a malignant lesion of the scapula. These findings highlight the importance of early diagnosis and treatment of suspicious lesions of the scapula to improve patient outcome.

AB - Backround: This study aimed to determine the frequency and distribution of bone tumours of the scapula as well as the histological and anatomical characteristics of these rare lesions in a large case series.Methods: The records of all lesions of the scapula collected from 1975 to 2018 in our bone tumour registry and institute of pathology were evaluated. During these 43 years, 223 cases were identified. Analysis included assessment of age, gender, side, imaging findings, tumour location, and histological evaluation with the assignment of each lesion to one of the bone tumours according to the World Health Organization (WHO) classification of bone tumours.Results: Bone tumours of the scapula were found in 193 cases. Mean patient age was 38.4 years (2.6-82.4). Most of the lesions were of cartilage origin (47%). 59 bone tumours were benign (30.6%), 29 were intermediate (15.0%), and 105 were malignant (54.4%). The most commonly found bone tumour was Osteochondroma (23.3%), followed by Chondrosarcoma (17.6%), Bone metastases (16.6%), Ewing sarcoma (8.8%), and Osteosarcoma (7.8%). The percentage of malignant bone tumours increased with increasing age. In patients >50 years of age, 91% had a malignant lesion of the scapula.Conclusions: Evaluation of 193 bone tumours of the scapula revealed a high incidence of malignancy in this series, while increased patient age was identified as a potential risk factor for the development of a malignant lesion of the scapula. These findings highlight the importance of early diagnosis and treatment of suspicious lesions of the scapula to improve patient outcome.

U2 - 10.1016/j.jbo.2019.100258

DO - 10.1016/j.jbo.2019.100258

M3 - SCORING: Journal article

C2 - 31497502

VL - 18

SP - 100258

JO - J BONE ONCOL

JF - J BONE ONCOL

SN - 2212-1374

ER -